These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 27012041

  • 21. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway.
    Mao J, Hu X, Pang P, Zhou B, Li D, Shan H.
    Oncol Rep; 2017 Jul; 38(1):393-401. PubMed ID: 28560434
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B, Wang X, Zhang L, Li D, Liu X, Song G, Cao H, Zhu J, Li H.
    Technol Cancer Res Treat; 2019 Jan 01; 18():1533033819828709. PubMed ID: 30786836
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T, Hirschfeld M, Rücker G, Jaeger M, Boas J, Iborra S, Mayer S, Gitsch G, Stickeler E.
    BMC Cancer; 2015 Mar 28; 15():193. PubMed ID: 25886191
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.
    Clin Chem; 2015 Aug 28; 61(8):1098-106. PubMed ID: 26056355
    [Abstract] [Full Text] [Related]

  • 31. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
    Eissa S, Matboli M, Shehata HH.
    Transl Res; 2015 Mar 28; 165(3):417-27. PubMed ID: 25445205
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K, Zhao S, Wang Q, Yang HS, Zhu J, Ma R.
    Ann Surg Oncol; 2015 Dec 28; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [Abstract] [Full Text] [Related]

  • 36. P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
    Laudato S, Patil N, Abba ML, Leupold JH, Benner A, Gaiser T, Marx A, Allgayer H.
    Int J Cancer; 2017 Nov 01; 141(9):1879-1890. PubMed ID: 28656629
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Circulating microRNA-based screening tool for breast cancer.
    Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.
    Oncotarget; 2016 Feb 02; 7(5):5416-28. PubMed ID: 26734993
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.